RPG Life Sciences invests up to Rs 65.68 Crore in wholly owned subsidiary RPG Active Pharma Limited
RPG Life Sciences Limited has made an investment of up to Rs 65,68,60,500 through a subscription in the Rights Issue of equity shares of its wholly owned subsidiary, RPG Active Pharma Limited (RPGAP).The investment was executed via cash consideration through remittance through a normal banking channel. With this proposed current investment, which involved acquiring 21,89,535 equity shares of face value Re 10 each, the Company's shareholding in RPGAP remains at 100%.
RPG Active Pharma Limited (RPGAP) was incorporated on December 24, 2025. As a pharmaceutical company, it is yet to commence operations and currently has no turnover. The company possesses an authorized share capital of Rs 7,00,00,000 and a paid-up capital of Rs 1,16,85,000.
The transaction involves the acquisition of shares in this wholly owned subsidiary. RPG Life Sciences confirmed that the investment is at arm's length, constituting a related party transaction under applicable regulations. The company’s shareholding post the proposed investment remains unchanged at 100%.
RPGLIFE Stock Price Movement
RPG Life Sciences Limited shares slipped by 2.07% on Friday, settling at ₹2,782.3 after closing down ₹58.50 from the previous close. The stock traded a volume of 14,339 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.